Bronchitis – Asthma (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Bronchitis – Asthma drug offered from Newton Laboratories, Inc.. This Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
NON-PROPRIETARY NAME: | Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Camphora, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Hepar sulph. calc., Histaminum hydrochloricum, Ipecac., Kali |
SUBSTANCE NAME: | INFLUENZA A VIRUS; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA; EUCALYPTUS GLOBULUS LEAF; CA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2011-06-01 |
END MARKETING DATE: | 0000-00-00 |
Bronchitis – Asthma HUMAN PRESCRIPTION DRUG Details:
Item Description | Bronchitis – Asthma from Newton Laboratories, Inc. |
LABELER NAME: | Newton Laboratories, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 3; 3; 3; 30([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; ) |
START MARKETING DATE: | 2011-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55714-4407_4e0446dd-eef0-bab4-8096-85d3b79f4263 |
PRODUCT NDC: | 55714-4407 |
APPLICATION NUMBER: | |
Other INFLUENZA A VIRUS; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; BRYONIA ALBA ROOT; CAMPHOR (NATURAL); CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; DROSERA ROTUNDIFOLIA; EUCALYPTUS GLOBULUS LEAF; CA Pharmaceutical Manufacturers / Labelers: